Medical Economics January 10, 2024
Americans pay more, but that could change when Medicare begins negotiating prices.
If your patients are complaining about high drug prices around the United States, they have good reason.
Patients in the United States pay more for brand name prescription medications than patients in other countries, according to data compiled by The Commonwealth Fund. American drug prices are almost three times the average of other member nations of the Organisation for Economic Co-operation and Development, based on 2022 prices.
The U.S. Centers for Medicare and Medicaid Services has new authority to negotiate prices of some drugs for Medicare, as allowed in the federal Inflation Reduction Act of 2022.
Bargaining will start next month on the first 10 drugs for prices...
Today's Sponsors
Today's Sponsor